These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 34997835)

  • 61. Comparative oral bioavailability of non-fixed and fixed combinations of artesunate and amodiaquine in healthy Indian male volunteers.
    Fortin A; Verbeeck RK; Jansen FH
    Eur J Clin Pharmacol; 2011 Mar; 67(3):267-75. PubMed ID: 20949263
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Fed and Fasted Single-dose Assessment of Bioequivalence of Dapagliflozin and Metformin Extended-release Fixed-dose Combination Tablets Relative to Single-component Dapagliflozin and Metformin Extended-release Tablets in Healthy Subjects.
    Boulton DW; Chang M; Griffen SC; Kitaura C; Lubin S; Pollack A; LaCreta F
    Clin Ther; 2016 Jan; 38(1):99-109. PubMed ID: 26682500
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Bioequivalence of saxagliptin/metformin immediate release (IR) fixed-dose combination tablets and single-component saxagliptin and metformin IR tablets in healthy adult subjects.
    Upreti VV; Keung CF; Boulton DW; Chang M; Li L; Tang A; Hsiang BC; Quamina-Edghill D; Frevert EU; Lacreta FP
    Clin Drug Investig; 2013 May; 33(5):365-74. PubMed ID: 23549864
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Pharmacokinetic comparison of gemigliptin 50 mg and metformin 500 mg as a fixed-dose combination and loose combination
.
    Lee SW; Park SI; Lee S; Chung JY; Yu KS
    Int J Clin Pharmacol Ther; 2019 Feb; 57(2):117-124. PubMed ID: 30574864
    [TBL] [Abstract][Full Text] [Related]  

  • 65. An interaction study with cimetidine and the new angiotensin II antagonist valsartan.
    Schmidt EK; Antonin KH; Flesch G; Racine-Poon A
    Eur J Clin Pharmacol; 1998 Feb; 53(6):451-8. PubMed ID: 9551704
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Investigation of bioequivalence, safety, and tolerability of a fixed-dose combination of nifedipine GITS and candesartan compared with the corresponding loose-dose combination under fed conditions
.
    Thomas D; Liu Y; Stein H; Weimann B
    Int J Clin Pharmacol Ther; 2019 Aug; 57(8):420-428. PubMed ID: 31232274
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Pharmacokinetics and Bioequivalence of a Generic Fixed-Dose Combination Tablet of Metformin Hydrochloride/Vildagliptin Versus a Branded Product in Healthy Chinese Subjects Under Fed and Fasting Conditions.
    Ye L; Li B; Ling N; Gao Y; Tao X; Cai S; Wang Y; Chen S; Wang F
    Clin Pharmacol Drug Dev; 2022 Jan; 11(1):63-70. PubMed ID: 34273258
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Pharmacokinetic Properties of Ibuprofen (IBU) From the Fixed-Dose Combination IBU/Caffeine (400/100 mg; FDC) in Comparison With 400 mg IBU as Acid or Lysinate Under Fasted and Fed Conditions-Data From 2 Single-Center, Single-Dose, Randomized Crossover Studies in Healthy Volunteers.
    Weiser T; Schepers C; Mück T; Lange R
    Clin Pharmacol Drug Dev; 2019 Aug; 8(6):742-753. PubMed ID: 30897305
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Bioequivalence of saxagliptin/metformin extended-release (XR) fixed-dose combination tablets and single-component saxagliptin and metformin XR tablets in healthy adult Chinese subjects.
    Gummesson A; Li H; Gillen M; Xu J; Niazi M; Hirshberg B
    Clin Drug Investig; 2014 Nov; 34(11):763-72. PubMed ID: 25269885
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Effect of food on the pharmacokinetics of canagliflozin/metformin (150/1,000 mg) immediate-release fixed-dose combination tablet in healthy participants.
    Murphy J; Wang SS; Stieltjes H; Wajs E; Devineni D
    Int J Clin Pharmacol Ther; 2015 Mar; 53(3):256-64. PubMed ID: 25546166
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Bioequivalence of a darunavir/cobicistat fixed-dose combination tablet versus single agents and food effect in healthy volunteers.
    Kakuda TN; Van De Casteele T; Petrovic R; Neujens M; Salih H; Opsomer M; Hoetelmans RM
    Antivir Ther; 2014; 19(6):597-606. PubMed ID: 24964392
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Bioequivalence of fixed-dose combination RIN®-150 to each reference drug in loose combination.
    Wang HF; Wang R; O'Gorman M; Crownover P; Damle B
    Int J Tuberc Lung Dis; 2015 Mar; 19(3):333-8. PubMed ID: 25686143
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Effects of food on the pharmacokinetics of gemigliptin/metformin sustained-release 50/1,000 mg (25/500 mg x 2 tablets) fixeddose combination tablet in healthy male volunteers.
    Choi HY; Noh YH; Kim YH; Kim MJ; Lee SH; Kim JA; Kim B; Lim HS; Bae KS
    Int J Clin Pharmacol Ther; 2014 May; 52(5):381-91. PubMed ID: 24495314
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Effect of a single-dose rifampin on the pharmacokinetics of pitavastatin in healthy volunteers.
    Chen Y; Zhang W; Huang WH; Tan ZR; Wang YC; Huang X; Zhou HH
    Eur J Clin Pharmacol; 2013 Nov; 69(11):1933-8. PubMed ID: 23831870
    [TBL] [Abstract][Full Text] [Related]  

  • 75. A single-dose, randomized, open-label, two-period crossover bioequivalence study comparing a fixed-dose pediatric combination of lamivudine and stavudine tablet for oral suspension with individual liquid formulations in healthy adult male volunteers.
    Monif T; Reyar S; Tiwari HK; Tippabhotla SK; Khuroo A; Thudi NR; Ahmed S; Raghuvanshi R
    Arzneimittelforschung; 2009; 59(2):104-8. PubMed ID: 19338141
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Effect of the angiotensin receptor-neprilysin inhibitor sacubitril/valsartan on the pharmacokinetics and pharmacodynamics of a single dose of furosemide.
    Ayalasomayajula S; Schuehly U; Pal P; Chen F; Zhou W; Sunkara G; Langenickel TH
    Br J Clin Pharmacol; 2018 May; 84(5):926-936. PubMed ID: 29318651
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Bioequivalence of fixed-dose combinations of dapagliflozin and metformin with single-component tablets in healthy subjects and the effect of food on bioavailability.
    de Bruin TW; Reele S; Hamer-Maansson JE; Parikh S; Tang W
    Clin Pharmacol Drug Dev; 2016 Mar; 5(2):118-30. PubMed ID: 27138025
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Pharmacokinetic Interaction Between Telmisartan and Rosuvastatin/Ezetimibe After Multiple Oral Administration in Healthy Subjects.
    Kim CH; Kang SI; Shin D
    Adv Ther; 2021 Feb; 38(2):1094-1105. PubMed ID: 33326064
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Relative Bioavailability of Fixed-Dose Combinations of Tamsulosin and Dutasteride: Results From 2 Randomized Trials in Healthy Male Volunteers.
    Burns O; Zhu J; Manyak MJ; Ravindranath R; Koosha F; Haque N; Chung S
    Clin Pharmacol Drug Dev; 2018 May; 7(4):422-434. PubMed ID: 28800206
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Comparative Pharmacokinetics Between a Fixed-Dose Combination of Pitavastatin/Valsartan 4/160 mg and the Corresponding Individual Components Through a Partial Replicated Crossover Design in Healthy Male Subjects.
    Na JY; Yang E; Kim JH; Kwon IS; Jin EH; Yu KS; Kim J; Lee S; Hong JH
    Clin Pharmacol Drug Dev; 2022 May; 11(5):615-622. PubMed ID: 34997835
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.